• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心胸外科手术后血管麻痹综合征:病理生理学综述及治疗选择更新。

Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.

机构信息

Department of Medicine, Emory University, Emory Critical Care Center, Atlanta, GA, USA.

Emory Johns Creek Hospital, 6325 Hospital Parkway, Johns Creek, GA, 30097, USA.

出版信息

Crit Care. 2020 Feb 4;24(1):36. doi: 10.1186/s13054-020-2743-8.

DOI:10.1186/s13054-020-2743-8
PMID:32019600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7001322/
Abstract

Vasoplegic syndrome is a common occurrence following cardiothoracic surgery and is characterized as a high-output shock state with poor systemic vascular resistance. The pathophysiology is complex and includes dysregulation of vasodilatory and vasoconstrictive properties of smooth vascular muscle cells. Specific bypass machine and patient factors play key roles in occurrence. Research into treatment of this syndrome is limited and extrapolated primarily from that pertaining to septic shock, but is evolving with the expanded use of catecholamine-sparing agents. Recent reports demonstrate potential benefit in novel treatment options, but large clinical trials are needed to confirm.

摘要

血管麻痹综合征是心胸外科手术后的常见并发症,其特征为高心输出量性休克状态,伴有全身血管阻力降低。其病理生理学机制复杂,包括血管平滑肌细胞舒缩功能失调。特定的体外循环机器和患者因素在其发生中起着关键作用。针对该综合征的治疗研究有限,主要从脓毒性休克的相关研究中推断而来,但随着儿茶酚胺节约剂的广泛应用,治疗方法也在不断发展。最近的报告显示,新型治疗选择可能具有潜在益处,但仍需要大型临床试验来证实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf4/7001322/c191b8707698/13054_2020_2743_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf4/7001322/4d3cabc4b025/13054_2020_2743_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf4/7001322/c191b8707698/13054_2020_2743_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf4/7001322/4d3cabc4b025/13054_2020_2743_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf4/7001322/c191b8707698/13054_2020_2743_Fig2_HTML.jpg

相似文献

1
Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.心胸外科手术后血管麻痹综合征:病理生理学综述及治疗选择更新。
Crit Care. 2020 Feb 4;24(1):36. doi: 10.1186/s13054-020-2743-8.
2
[Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].[体外循环心脏手术期间的血管麻痹综合征及其血管加压素治疗]
Rev Med Chil. 2011 Mar;139(3):368-72. Epub 2011 Aug 25.
3
Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.心血管手术后的血管麻痹——病理生理学与靶向治疗
J Cardiothorac Vasc Anesth. 2018 Apr;32(2):1013-1022. doi: 10.1053/j.jvca.2017.10.032. Epub 2017 Oct 27.
4
Methylene Blue for Vasoplegic Syndrome.亚甲蓝治疗血管麻痹综合征
Heart Surg Forum. 2017 Oct 31;20(5):E234-E238. doi: 10.1532/hsf.1806.
5
Vasopressin and methylene blue: alternate therapies in vasodilatory shock.血管加压素与亚甲蓝:血管舒张性休克的替代疗法
Semin Cardiothorac Vasc Anesth. 2010 Sep;14(3):186-9. doi: 10.1177/1089253210379271.
6
Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.心肺转流术后难治性血管扩张性休克使用羟钴胺静脉注射而不使用亚甲蓝。
Am J Case Rep. 2021 Jun 18;22:e930890. doi: 10.12659/AJCR.930890.
7
Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.用于体外循环后血管麻痹性休克的合成人血管紧张素II
J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3080-3084. doi: 10.1053/j.jvca.2019.03.004. Epub 2019 Mar 8.
8
Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.心血管手术后血管麻痹综合征:病理生理学和以结果为导向的治疗管理综述。
J Card Surg. 2021 Oct;36(10):3749-3760. doi: 10.1111/jocs.15805. Epub 2021 Jul 12.
9
Intraoperative vasoplegia: methylene blue to the rescue!术中血管麻痹:亚甲蓝来救援!
Curr Opin Anaesthesiol. 2018 Feb;31(1):43-49. doi: 10.1097/ACO.0000000000000548.
10
Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.心脏手术患者血管麻痹综合征:文献综述。
AACN Adv Crit Care. 2021 Jun 15;32(2):137-145. doi: 10.4037/aacnacc2021299.

引用本文的文献

1
Decreased vasoregulatory dysfunction associated with intra-operative hemoadsorption treatment is related to mitigated post-transplant procalcitonin rather than cytokine or complement response.与术中血液吸附治疗相关的血管调节功能障碍减轻与移植后降钙素原减轻有关,而非细胞因子或补体反应。
Front Med (Lausanne). 2025 Aug 13;12:1541519. doi: 10.3389/fmed.2025.1541519. eCollection 2025.
2
Methylene blue in the critical care setting.重症监护环境中的亚甲蓝。
World J Crit Care Med. 2025 Sep 9;14(3):105350. doi: 10.5492/wjccm.v14.i3.105350.
3
Angiotensin II, conventional vasopressor therapy, and mortality in shock: a large, multicenter, propensity score-weighted analysis.

本文引用的文献

1
A Pilot, Double-Blind, Randomized, Controlled Trial of High-Dose Intravenous Vitamin C for Vasoplegia After Cardiac Surgery.一项关于心脏手术后血管麻痹的高剂量静脉注射维生素 C 的先导、双盲、随机、对照试验。
J Cardiothorac Vasc Anesth. 2020 Feb;34(2):409-416. doi: 10.1053/j.jvca.2019.08.034. Epub 2019 Aug 24.
2
Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury.血管加压素治疗与急性肾损伤时的血压管理。
Semin Nephrol. 2019 Sep;39(5):462-472. doi: 10.1016/j.semnephrol.2019.06.006.
3
Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
血管紧张素II、传统血管升压药治疗与休克死亡率:一项大型多中心倾向评分加权分析
Ann Intensive Care. 2025 Jul 23;15(1):104. doi: 10.1186/s13613-025-01522-3.
4
Vasoplegic Syndrome under Extracorporeal Membrane Oxygenation: Successful Treatment with Methylene Blue.体外膜肺氧合支持下的血管麻痹综合征:亚甲蓝治疗成功
Arq Bras Cardiol. 2025 Jul 7;122(5):e20250070. doi: 10.36660/abc.20250070. eCollection 2025.
5
Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgery.心脏手术后血管麻痹患者血管紧张素 II 给药时机与预后的关系。
JTCVS Open. 2025 Apr 25;25:280-293. doi: 10.1016/j.xjon.2025.04.014. eCollection 2025 Jun.
6
Ascorbic acid and microcirculation in cardiothoracic surgery: a pilot feasibility trial and matched cohort study.抗坏血酸与心胸外科手术中的微循环:一项初步可行性试验及匹配队列研究。
J Cardiothorac Surg. 2025 May 22;20(1):234. doi: 10.1186/s13019-025-03486-8.
7
Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system.与氨氯地平相关的不良事件:一项使用美国食品药品监督管理局不良事件报告系统的药物警戒研究。
Front Cardiovasc Med. 2025 May 6;12:1504671. doi: 10.3389/fcvm.2025.1504671. eCollection 2025.
8
Current insights on temporary mechanical circulatory support in adults with post-cardiotomy cardiogenic shock.心脏术后心源性休克成人患者临时机械循环支持的当前见解
Eur Heart J Suppl. 2025 Feb 4;27(Suppl 4):iv12-iv22. doi: 10.1093/eurheartjsupp/suaf005. eCollection 2025 Apr.
9
Intraoperative Hemoadsorption in Heart Transplant Surgery: A 5-Year Experience.心脏移植手术中的术中血液吸附:5年经验
J Cardiovasc Dev Dis. 2025 Mar 28;12(4):119. doi: 10.3390/jcdd12040119.
10
Vasoplegic syndrome in cardiac surgery: bridging therapeutic gaps with best practices and future research.心脏手术中的血管麻痹综合征:用最佳实践和未来研究弥合治疗差距
Interdiscip Cardiovasc Thorac Surg. 2025 Mar 29;40(4). doi: 10.1093/icvts/ivaf075.
用于体外循环后血管麻痹性休克的合成人血管紧张素II
J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3080-3084. doi: 10.1053/j.jvca.2019.03.004. Epub 2019 Mar 8.
4
A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy.基于药物治疗最新进展的血管麻痹治疗系统方法。
J Cardiothorac Vasc Anesth. 2019 May;33(5):1310-1314. doi: 10.1053/j.jvca.2018.11.025. Epub 2018 Nov 24.
5
Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome.血管扩张性休克后使用血管紧张素 II。
Ann Thorac Surg. 2019 Jul;108(1):e5-e7. doi: 10.1016/j.athoracsur.2018.11.047. Epub 2018 Dec 21.
6
Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for Use.羟钴胺素治疗血管麻痹:当前文献综述及使用考量
J Cardiothorac Vasc Anesth. 2019 Apr;33(4):894-901. doi: 10.1053/j.jvca.2018.08.017. Epub 2018 Aug 11.
7
Angiotensin II: a new therapeutic option for vasodilatory shock.血管紧张素II:血管舒张性休克的一种新治疗选择。
Ther Clin Risk Manag. 2018 Jul 26;14:1287-1298. doi: 10.2147/TCRM.S150434. eCollection 2018.
8
Definitions and pathophysiology of vasoplegic shock.血管扩张性休克的定义和病理生理学。
Crit Care. 2018 Jul 6;22(1):174. doi: 10.1186/s13054-018-2102-1.
9
Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.血管加压素联合儿茶酚胺类血管加压药与儿茶酚胺类药物单独用于分布性休克患者心房颤动的比较:系统评价和荟萃分析。
JAMA. 2018 May 8;319(18):1889-1900. doi: 10.1001/jama.2018.4528.
10
Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery.亚甲蓝用于心脏手术后血管麻痹综合征
Indian J Crit Care Med. 2018 Mar;22(3):168-173. doi: 10.4103/ijccm.IJCCM_494_17.